Cancer mortality trends in two cohorts of elderly people having different life-styles

Aging Clinical and Experimental Research

Volumn 11, Issue 1, 1999, Pages 21-29

  Mazza, A ^a   Casiglia, E ^a,c   Scarpa, R ^b   Sica, E ^a   Biasin, R ^a   Privato, G ^a   Pizziol, A ^a   Pessina, A C ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b Unit of Radiology   (Italy)

^c NONE   (Italy)

Author keywords

Cancer mortality; Elderly; Epidemiology; Life style; Risk factors

Indexed keywords

AGE; AGED; AGING; ALCOHOL CONSUMPTION; ARTICLE; CANCER MORTALITY; FEMALE; HUMAN; HYGIENE; ITALY; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; RURAL AREA; SMOKING;

NICOTIANA TABACUM;

EID: 0032957120     PISSN: 03949532     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03399632     Document Type: Article

References (73)

1. Ebrahim S.: Public health implications of ageing. J. Royal Coll. Phys. 29: 207-215, 1995.
2. Manton K.G., Stallard E., Liu K.: Forecast of active life expectancy: policy and fiscal implications. J. Gerontol. 48: 11-26, 1993.
3. Sallar A.M., Hogg R.S., Schechter M.T.: Survival after age 80. N. Engl. J. Med. 334: 537-538, 1996.
4. Rosenwaike I., Logue B.: Accuracy of death certificate ages for the extreme aged. Demography 20: 569-585, 1983.
5. World Health Statistics Annual, 1993. World Health Organization, Geneva, 1994.
6. Kannisto A.U.: Development of oldest-old mortality, 1950-1990: evidence from 28 developed countries. Odense University Press, Odense, Denmark, 1994.
7. Manton K.G., Vaupel J.W.: Survival after the age of 80 in the United States, Sweden, France, England, and Japan. N. Engl. J. Med. 333: 1232-1235, 1995.
8. Kohn R.R.. Cause of death in very old people. JAMA 247: 2793-2797, 1982.
9. Kaplan G.A., Seeman T.E., Cohen R.D., Knudsen L.P., Guralnik J.: Mortality among the elderly in Alameda County Study: behavioural and demographic risk factors. Am. J. Public Health 77: 303-312, 1987.
10. Lee D.J., Mrakides K.S.: Activity and mortality among aged persons over an eight-year period. J. Gerontol. 45: 39-42, 1990.
11. Yancik R., Ries L.A.: Cancer in older persons. Magnitude of the problem - how do we apply what we know ? Cancer 74: 1995-2003, 1994.
12. Casiglia E., Spolaore P., Ginocchio G., Colangeli G., Di Menza G., Marchioro M., Mazza A., Ambrosio G.B.: Predictors mortality in very old subjects aged 80 years or over. Eur. J. Epidemiol. 9: 577-586, 1993.
13. Levi F., La Vecchia C., Lucchini F., Negri E.: Worldwide trends in cancer mortality in the elderly, 1955-1992. Eur. J. Cancer 32: 652-672, 1996.
14. Miller R.A.: Gerontology as Oncology. Research of aging as the key to the understanding of cancer. Cancer 68: 2496-2501, 1991.
15. Newell G.R., Spitz M.R., Sider J.G.: Cancer and age. Semin. Oncol. 16: 3-9, 1989.
16. Hoel D.G., Davis D.L., Miller A.B., Sondik E.J., Swerdlow A.J.: Trends in cancer mortality in 15 industrialized countries, 1969-1986. J. Natl.Cancer Inst. 84: 313-320, 1992.
17. Smith D.W.E.: Cancer mortality at very old ages. Cancer 77: 1367-1372, 1996.
18. Miles T.P., Bernard M.A.: Morbidity, disability and health status of black American elderly: a new look at the oldest-old. J. Am. Geriatr. Soc. 40: 1047-1054, 1992.
19. Ruigómez A., Alonso J., Antó M.J.: Relationship of health behaviours to five-years mortality in an elderly cohort. Age Ageing 24: 113-119, 1995.
20. Higginson J.: Environmental carcinogenesis. Cancer 72: 971-977, 1993.
21. Peto R., Row F.J.C., Lee P.N., Levy L., Clack J.: Cancer and aging in mice and men. Br. J. Cancer 32: 411-426, 1975.
22. Kaesberg P.R., Ershler W.B.: The importance of immunosenescence in the incidence and malignant properties of cancer in hosts of advances age. J. Gerontol. 44: 63-66, 1989.
23. Kaesberg P.R., Ershler W.B.: The change in tumor aggressiveness with age: lessons from experimental animals. Semin. Oncol. 16: 28-33, 1989.
24. Casiglia E., Spolaore P., Mormino P., Maschio O., Colangeli G., Celegon L., Tittoto L., Pasinato A., Ambrosio G.B.: The CASTEL project (CArdiovascular STudy in the ELderly): protocol, study design and preliminary results of the initial screening. Cardiologia 36: 569-576, 1991.
25. Casiglia E., Spolaore P., Ginocchio G., Colangeli G., Maschio O., Marchioro M., Lanzieri M., Ambrosio G.B.: Proteinuria predicts mortality among elderly but not among "very older" subjects. J. Nephrol. 5: 89-93, 1992.
26. Descovich G.C., Dalmonte G., Dormi A., Braiato A., Mannino G., Benassi M.S., Gaddi A., Sangiorgi Z., Trivelli N., Lenzi S.: The Brisighella Study: a community survey. In: Lenzi S., Descovich G.C. (Eds.), Atherosclerosis and cardiovascular disease. MPT Press, Norwell MA, USA, 1987, pp. 215-222.
27. Zanetti G., Colussi P., Pagnan A., Dal Palù C.: Comportamento della colesterolemia totale nei pazienti affetti da neoplasie maligne: studio epidemiologico trasversale. Giorn. Arterioscl. 15: 85-90, 1990.
28. Rose G.A., Blackburn H., Gillum R.F., Prineas R.J.: Cardiovascular survey methods. World Health Organization, Geneva, 1982.
29. Tietz N.W., Shuey D.F., Huang W.Y., Rauh D.F., Shuey D.F.: Laboratory tests in the differential diagnosis of hyperamylasemia. Clin. Chem. 32: 301-317, 1986.
30. Colton T., Buxbaum R.C.: Motor vehicle inspection and motor vehicle accident mortality. Am. J. Public Health 58: 1090, 1968.
31. Cox D.R.: Regression models and life tables. J. R. Stat. Soc. 34, Series B, 1972, pp. 187-220.
32. Cox D.R., Oakes D.: Analysis of survival data. Chapman and Hall, London, 1984.
33. Lopez A.D.: Competing causes of death. A review of recent trends in mortality in industrialized countries with special reference to cancer. Ann. N.Y. Acad. Sci. 609: 58-76, 1990.
34. Muirs C.S.: Epidemiology, basic science and the prevention of cancer: implications for the future. Cancer Res. 50: 6441-6448, 1990.
35. Yancik R., Ries G.L.: Cancer in the aged. An epidemiologic perspective on treatment issues. Cancer 68: 2502-2510, 1991.
36. Doll R., Peto R.: The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. Oxford University Press, New York, 1981.
37. Byers T., Perry G.: Dietary carotenes, vitamin C and vitamin E as prospective antioxidants human cancers. Annu. Rev. Nutr. 12:139-159, 1992.
38. Simopoulos A.P.: Nutritional cancer risks derived from energy and fat. Med. Oncol. Tumor Pharm. 4: 227-239, 1987.
39. Boyle P., Veronesi U., Tubiana M., Alexander F.E., Calais da Silva F., Denis L.J., Freire J.M., Hakama M., Hirsch A., Kroes R., La Vecchia C., Maisonneuve P., Martin-Moreno J.M., Newton-Bishop J., Pindborg J.J., Saracci R., Scully C., Standaert B., Storm H., Blanco S., Malbois R., Bleehen N., Dicato M., Plesnicar S.: European School of Oncology advisory report to the European commission for the "Europe Against Cancer Programme", European Code Against Cancer. Eur. J. Cancer 31: 1395-1405, 1995.
40. Austoker J.: Cancer prevention in primary care. Cancer prevention: setting the scene. BMJ 308: 1415-1420, 1994.
41. Kanstrom L., Holm L.E.: Promoting dietary change in the Stockholm cancer prevention program. Cancer Detect. Prev. 16: 203-210, 1992.
42. Peto R., Lopez A.D., Boreham J., Thun M., Heath C. Jr.: Mortality from tobacco in developed countries: indirect estimation from national vital statistics. Lancet 339: 1268-1278, 1992.
43. McLaughlin J.K., Hrubec Z., Blot W.J., Fraumeni J.F. Jr.: Smoking and cancer mortality among U.S. veterans: a 26-year follow-up. Int. J. Cancer 60: 190-193, 1995.
44. Pisani P., Lopez A.D., Masuyer E.: At least one in seven cases of cancer is caused by smoking. Global estimates Parkin for 1985. Int. J. Cancer 59: 494-504, 1994.
45. Sterling T.D., Rosenbaum W.L., Weinkarn J.J.: Analysis of the relationship between smokeless tobacco and cancer based on data from the national mortality follow back survey. J. Clin. Epidemiol. 45: 223-231, 1992.
46. Ronneberg A., Lund K.E., Hafstad A.: Lifetime smoking habits among Norwegian men and women born between 1890 and 1974. Int . J. Epidemiol. 23: 267-276, 1994.
47. Maier H., Dietz A., Gewelke U., Heller W.D., Weidauer H.: Tobacco and alcohol and the risk of head and neck cancer. Clin. Invest. 70: 320-327, 1992.
48. Kabat G.C., Chang C.J., Wynder E.L.: The role of tobacco, alcohol use, and body mass index in oral and pharyngeal cancer. Int. J. Epidemiol. 23: 1137-1144, 1994.
49. Mastrangelo G., Malusa E., Veronese C., Zucchero A., Marzia A., Boscolo Bariga A.: Mortality from lung cancer and other diseases related to smoking among fishermen in Northeast Italy. Occup. Environ. Med. 52: 150-153, 1995.
50. Reizenstein P., Modan B., Kuller L.H.: The quandary of cancer prevention. J. Clin. Epidemiol. 47: 575-581, 1994.
51. Vainio H., Matos E., Boffetta P., Kogevinas M., Wilbourn J.: Occupational cancer in developing and new industrialized countries. Ann. Acad. Med. Singapore 22: 170-181, 1993.
52. Doll R.: Are we winning the fight against cancer? An epidemiological assessment. EARC-Muhlbock Memorial Lecture. Eur. J. Cancer 25: 500-508, 1990.
53. Doll R.: Progress against cancer: An epidemiological assessment. The 1991 John C. Cassell Memorial Lecture. Am. J. Epidemiol. 134: 675-688, 1991.
54. La Vecchia C., Negri E., Decarli A., Fasoli M., Cislaghi C.: Cancer mortality in Italy: an overview of age-specific and age-standardised trends from 1955 to 1984. Tumori 76: 87-166, 1990.
55. Francescon A., Gessoni G., Manoni F., Scarpa R.: Infezione da virus C nell'anziano: studio sierologico e valutazione dei fattori di rischio. Giorn. Geront. 43: 145-151, 1995.
56. Gessoni G., Manoni F.: Prevalence of anti-hepatitis C virus antibodies among teenagers in the Venetian area: a siero-epidemiological study. Eur. J. Med. 2: 79-82, 1993.
57. Gessoni G., Manoni F., Prosperi A., Sanavio C., Tedeschi P., Francescon A., Longo L., Giordano R.: L'infezione da HCV: importanza come fattore di rischio nel carcinoma epatocellulare. Giorn. Ven. Sci. Med. 45: 71-76, 1993.
58. Reuben D.B., Mor V.: Dyspnea in terminally cancer patients. Chest 89: 234-236, 1986.
59. Escalante C.P., Martin C.G., Elting L.S.: Dyspnea in cancer patients. Etiology, resource utilization, and survival implications in a managed care world. Cancer 78: 1314-1319, 1996.
60. Hiatt R.A., Fireman B.H.: Serum uric acid unrelated to cancer incidence in humans. Cancer Res. 48: 2916-2918, 1988.
61. Levine W., Dyer A.R., Shekelle R.B, Schoenberger J.A., Stamler J.: Serum uric acid and 11.5 years mortality of middle-aged women: findings of the Chicago Heart Association Detection Project in Industry. J. Clin. Epidemiol. 42: 257-267, 1989.
62. Rustin G.J.: Circulating tumour markers in the management of human cancer. In: Daar A.S. (Ed.), Tumour Markers in Clinical Practice: Concepts and Applications. Blackwell, Oxford, UK, 1987, pp. 204-227.
63. Fishman W.H.: The 1993 ISOBM Abbott Award Lecture. Isoenzymes, tumour markers and oncodevelopmental biology. Tumour biol. 16: 394-402, 1995.
64. Wolf P.L.: Clinical significance of increased or decreased serum alkaline phosphatase isoenzymes. Clin. Lab. Med. 6: 525-532, 1986.
65. Borghi L., Alberti A., Zocca A.: La frazione biliare della AP nelle neoplasie epatiche. G. Clin. Med. 63: 271-273, 1986.
66. Bacci P., Picci P., Ferrari S.: Prognostic significance of serum AP in patients with osteosarcoma treated with adjuvant or neoadjuvant chemotherapy. Cancer 11: 1224-1230, 1993.
67. Millan J.L., Fishman W.H.: Biology of human alkaline phosphatases with special reference to cancer. Crit. Rev. Clin. Lab. Sci. 32: 1-39, 1995.
68. Erickson K.L., Hubbard N.E.: Dietary fish oil modulation of macrophage tumoricidal activity. Nutrition 12: S34-S38, 1996.
69. McCarty M.F.: Fish oil may impede tumour angiogenesis and invasiveness by down-regulating protein kinase C and modulating eicosanoid production. Med. Hypotheses 46: 107-115, 1996.
70. Li F.P.: Familial cancer syndromes and clusters. Curr. Probl. Cancer 14: 73-114, 1990.
71. Shields P.G.: Inherited factors and environmental exposures in cancer risk. J. Occup. Med. 35: 34-41, 1993.
72. Goldgar D.E., Easton D.F., Cannon-Albrigth L.A., Sholnick M.H.: Systematic population-based assessment of cancer risk in first degree relatives of cancer probands. J. Natl. Cancer Inst. 86: 1600-1608, 1994.
73. Tefre T., Ryberg D., Haugen A.: Human CYP1A1 (cytochrome P1450) gene: lack of association between the Msp 1 restriction fragment length polymorphism and incidence of lung cancer in a Norwegian population. Pharmacogenetics 1: 20-25, 1991.